MedPath

Evaluating the safety of Cystone Syrup in healthy volunteers

Phase 1
Registration Number
CTRI/2022/02/040337
Lead Sponsor
Himalaya Wellness Company
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Adult population:

1.Healthy adult subjects of either sex aged between >= 18 to <= 50 years.

2.Subjects willing to refrain taking any other similar medication during the study period

3.Adult subjects who have not participated in this kind of trial in the past 4 weeks

4.Adult subjects willing to sign informed consent and follow the study procedure.

Pediatric Population:

1.Healthy male and female pediatric subjects aged between >=2 years to <=12 years.

2.Parents/Guardians/Caregiver related to pediatric subjects < 7 years willing to give informed consent for his/her child to participate in the study.

3.Pediatric subjects aged > 7 years of age willing to provide oral consent for his/her participation in the study along with parents/guardians/caregiver consent (Refer protocol section 11.4, Informed Consent Process)

4.Pediatric Subjects willing to refrain taking any other similar medication during the study period

5.Pediatric subjects who have not participated in this kind of trial in the past 4 weeks.

6.Subjects willing to sign informed consent/assent (as applicable) and follow the study procedure.

Exclusion Criteria

1.Subjects with clinically significant serious cardiovascular, respiratory,

cerebrovascular, hepatic, renal disease, endocrinal, congenital or any other disorder.

2.A known history or present condition of allergic response to the study products its components or ingredients in the investigational product.

3.Pre-existing systemic disease necessitating long-term medications.

4.Subjects who refused to sign informed consent.

5.Pregnant and lactating women.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath